Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial.

[1]  B. Kerns,et al.  Developmental profiling of microRNAs in the human embryonic inner ear , 2018, PloS one.

[2]  Wei-Lien Wang,et al.  Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model , 2017, Modern Pathology.

[3]  A. D. Dei Tos,et al.  Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour. , 2017, European journal of cancer.

[4]  A. Shinagare,et al.  Metastatic Patterns of Solitary Fibrous Tumors: A Single-Institution Experience. , 2017, AJR. American journal of roentgenology.

[5]  Michael P. Snyder,et al.  Abstract 3616: Fix the fixation: effect of formalin fixation on targeted sequencing, variant calling and gene expression , 2016 .

[6]  M. Zeng,et al.  ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma , 2016, Oncotarget.

[7]  Robin L. Jones,et al.  The Current Status of Solitary Fibrous Tumor , 2016, International journal of surgical pathology.

[8]  V. Sondak,et al.  Clinical Characteristics and Outcomes for Solitary Fibrous Tumor (SFT): A Single Center Experience , 2015, PloS one.

[9]  F. Bertucci,et al.  Trabectedin in patients with advanced soft tissue sarcoma: a retrospective national analysis of the French Sarcoma Group. , 2015, European journal of cancer.

[10]  I. Judson,et al.  Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience , 2015, Clinical Sarcoma Research.

[11]  A. D. Dei Tos,et al.  Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour. , 2014, European journal of cancer.

[12]  F. Mertens,et al.  Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics , 2014, Modern Pathology.

[13]  G. Ball,et al.  Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  O. Larsson,et al.  Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor , 2013, Genes, chromosomes & cancer.

[15]  F. Coevorden,et al.  Prognosis of Solitary Fibrous Tumors: A Multicenter Study , 2013, Annals of Surgical Oncology.

[16]  L. Mariani,et al.  Response to chemotherapy of solitary fibrous tumour: a retrospective study. , 2013, European journal of cancer.

[17]  Wei-Lien Wang,et al.  The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis , 2013, Clinical Sarcoma Research.

[18]  P. O'dwyer,et al.  Autophagy Inhibition Sensitizes Colon Cancer Cells to Antiangiogenic and Cytotoxic Therapy , 2013, Clinical Cancer Research.

[19]  K. Pienta,et al.  Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing , 2013, Nature Genetics.

[20]  Daniel Auclair,et al.  Whole exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors , 2013, Nature Genetics.

[21]  C. Fletcher,et al.  WHO classification of tumours of soft tissue and bone , 2013 .

[22]  A. D. Dei Tos,et al.  Sunitinib malate in solitary fibrous tumor (SFT). , 2012 .

[23]  P. Fox,et al.  Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model , 2012, Modern Pathology.

[24]  U. Pastorino,et al.  High-grade Sarcomatous Overgrowth in Solitary Fibrous Tumors: A Clinicopathologic Study of 10 Cases , 2012, The American journal of surgical pathology.

[25]  A. Lazar,et al.  Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor , 2011, Cancer.

[26]  J. Mosquera,et al.  Expanding the Spectrum of Malignant Progression in Solitary Fibrous Tumors: A Study of 8 Cases With a Discrete Anaplastic Component—Is This Dedifferentiated SFT? , 2009, The American journal of surgical pathology.

[27]  Peter A Fasching,et al.  The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer , 2008, Breast Cancer Research.

[28]  Haesun Choi,et al.  Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  S. Dry,et al.  Atypical and malignant solitary fibrous tumors in extrathoracic locations: evidence of their comparability to intra-thoracic tumors. , 1998, The American journal of surgical pathology.

[30]  L. Hochholzer,et al.  Localized Benign and Malignant Fibrous Tumors of the Pleura: A Clinicopathologic Review of 223 Cases , 1989, The American journal of surgical pathology.